From: Functional recovery in a cohort of ECMO and non-ECMO acute respiratory distress syndrome survivors
 | Entire cohort | ECMO eligible cohort | ||||
---|---|---|---|---|---|---|
ECMO (n = 34) | Non-ECMO (n = 76) | p value | ECMO (n = 34) | “ECMO Eligible” (n = 30) | P value | |
Primary outcome | ||||||
FVC, % predicted | 72 (56, 82) | 70 (55, 82) | 0.7 | 72 (56, 82) | 70 (57, 78) | 0.60 |
Secondary outcomes | ||||||
FEV1, L | 2.1 (1.8, 2.9) | 2.1 (1.5, 2.6) | 0.43 | 2.1 (1.8, 2.9) | 2.3 (2.0, 2.9) | 0.44 |
FEV1, % predicted | 69 (58, 85) | 67 (55, 80) | 0.38 | 69 (58, 85) | 70 (57–77) | 0.60 |
FVC, L | 2.7 (2.1, 3.4) | 2.7 (2.1, 3.4) | 0.76 | 2.7 (2.1, 3.4) | 3.1 (2.5, 3.3) | 0.46 |
FEV1/FVC% | 84 (79, 87) | 80 (76, 86) | 0.18 | 84 (79, 87) | 80 (76, 89) | 0.67 |
TLC, L | 4.4 (3.3, 5.4) | 4.3 (3.4, 5.0) | 0.73 | 4.4 (3.3, 5.4) | 4.5 (3.6, 5.9) | 0.47 |
TLC, % predicted | 70 (58, 79) | 70 (62, 85) | 0.75 | 70 (58, 79) | 61 (56, 83) | 0.94 |
DLCO, % predicted | 63 (48, 86) | 64 (43, 79) | 0.49 | 63 (48, 86) | 62 (50, 75) | 0.87 |
6MWT, m | 367 (320, 444) | 306 (234, 358) | 0.12 | 367 (320, 444) | 368 (325, 390) | 0.84 |